• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较羧基麦芽糖铁和蔗糖铁复合物治疗妊娠期缺铁性贫血的随机对照试验。

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.

机构信息

Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.

Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

BMC Pregnancy Childbirth. 2019 Feb 4;19(1):54. doi: 10.1186/s12884-019-2200-3.

DOI:10.1186/s12884-019-2200-3
PMID:30717690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360702/
Abstract

BACKGROUND

To evaluate the efficacy and safety of intravenous Ferric Carboxymaltose. (FCM) in comparison with intravenous Iron sucrose complex (ISC) for treatment of iron deficiency anemia in pregnancy.

METHODS

A randomized clinical trial was conducted from (January 2016-August 2017). at a tertiary hospital. Pregnant women diagnosed with moderate to severe iron deficiency anaemia were screened for the study. One hundred patients were randomized to receive either intravenous FCM or ISC. Primary outcome was rise in hemoglobin (Hb) from baseline after 12 weeks. Secondary outcomes were change in RBC indices, serum iron studies, improvement in fatigue scores, number of visits and perinatal outcome.

RESULTS

Mean rise in Hb at 12 weeks was significantly higher in FCM group (29 g/L vs 22 g/L; p value < 0.01). FCM was associated with greater improvement in fatigue scores. Number of visits were significantly less in FCM group. No serious adverse events were noted in either group.

CONCLUSION

Treatment with FCM resulted in rapid replenishment of iron stores in pregnant women with significantly higher Hb rise over a 12 week period. The convenient dosing with lesser number of total doses to complete the treatment will lead to better compliance in community setting. CLINICAL TRIAL REGISTRATION ( WWW.CTRI.NIC.IN ): CTRI/2015/09/006224. Registered on 21/07/2017 (Trial registered retrospectively).

摘要

背景

评估静脉注射羧基麦芽糖铁(FCM)与静脉注射蔗糖铁复合物(ISC)治疗妊娠缺铁性贫血的疗效和安全性。

方法

一项随机临床试验于(2016 年 1 月至 2017 年 8 月)在一家三级医院进行。对诊断为中重度缺铁性贫血的孕妇进行了研究筛选。100 名患者被随机分为静脉注射 FCM 或 ISC 组。主要结局是 12 周后血红蛋白(Hb)从基线升高。次要结局是 RBC 指数、血清铁研究、疲劳评分改善、就诊次数和围产期结局的变化。

结果

FCM 组 12 周时 Hb 升高的平均值明显高于 ISC 组(29g/L 比 22g/L;p 值<0.01)。FCM 组的疲劳评分改善更明显。FCM 组的就诊次数明显减少。两组均未出现严重不良事件。

结论

FCM 治疗可迅速补充孕妇铁储备,在 12 周内 Hb 升高明显更高。方便的给药方式,较少的总剂量完成治疗,将导致社区治疗的更好依从性。临床试验注册(www.ctri.nic.in):CTRI/2015/09/006224. 于 2017 年 7 月 21 日注册(回顾性注册)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/eff1419b06c9/12884_2019_2200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/b69014d7a7bd/12884_2019_2200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/f94744adb596/12884_2019_2200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/eff1419b06c9/12884_2019_2200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/b69014d7a7bd/12884_2019_2200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/f94744adb596/12884_2019_2200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7068/6360702/eff1419b06c9/12884_2019_2200_Fig3_HTML.jpg

相似文献

1
Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.比较羧基麦芽糖铁和蔗糖铁复合物治疗妊娠期缺铁性贫血的随机对照试验。
BMC Pregnancy Childbirth. 2019 Feb 4;19(1):54. doi: 10.1186/s12884-019-2200-3.
2
Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.羧基麦芽糖铁与蔗糖铁治疗缺铁性贫血女性的有效性和安全性比较:IV期临床试验
BMC Womens Health. 2018 Jan 5;18(1):6. doi: 10.1186/s12905-017-0506-8.
3
Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.静脉注射羧基麦芽糖铁和蔗糖铁治疗妇产科患者缺铁性贫血的疗效和安全性比较:系统评价和荟萃分析。
Medicine (Baltimore). 2021 May 21;100(20):e24571. doi: 10.1097/MD.0000000000024571.
4
Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study.静脉注射羧麦芽糖铁和蔗糖铁治疗月经过多患者术前贫血的疗效和安全性比较:一项开放标签、多中心、随机研究。
J Obstet Gynaecol Res. 2019 Apr;45(4):858-864. doi: 10.1111/jog.13893.
5
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.比较羧基麦芽糖铁和蔗糖铁治疗因异常子宫出血导致的缺铁性贫血的随机对照试验。
Int J Gynaecol Obstet. 2016 Apr;133(1):43-8. doi: 10.1016/j.ijgo.2015.09.007. Epub 2015 Dec 23.
6
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.治疗炎症性肠病缺铁性贫血的干预措施。
Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD013529. doi: 10.1002/14651858.CD013529.pub2.
7
Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.比较长期血液透析患者的不同补铁策略:一项随机对照试验。
Clin J Am Soc Nephrol. 2021 Oct;16(10):1512-1521. doi: 10.2215/CJN.03850321. Epub 2021 Sep 1.
8
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.一项静脉注射羧基麦芽糖铁与静脉注射多糖铁复合物或口服硫酸亚铁治疗妊娠期缺铁性贫血的前瞻性随机对照试验。
Semin Hematol. 2018 Oct;55(4):223-234. doi: 10.1053/j.seminhematol.2018.04.006. Epub 2018 Apr 25.
9
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.静脉注射羧甲麦芽糖铁与蔗糖铁治疗成人缺铁性贫血的疗效和成本效益比较。
PLoS One. 2021 Aug 10;16(8):e0255104. doi: 10.1371/journal.pone.0255104. eCollection 2021.
10
Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.静脉注射羧麦芽糖铁与含糖氧化铁对日本月经过多所致缺铁性贫血患者疗效及安全性的比较:一项多中心、随机、开放标签非劣效性研究。
Int J Hematol. 2019 Jan;109(1):41-49. doi: 10.1007/s12185-018-2501-8. Epub 2018 Jul 23.

引用本文的文献

1
Intravenous Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia During Pregnancy: Effects on Maternal and Fetal Wellbeing-A Multicenter Retrospective Observational Study.静脉注射羧麦芽糖铁治疗孕期缺铁性贫血:对母婴健康的影响——一项多中心回顾性观察研究
Nutrients. 2025 Aug 19;17(16):2670. doi: 10.3390/nu17162670.
2
Randomized, Positive-Controlled Study on the Efficacy and Safety of Oral Polysaccharide-Iron Complex Therapy in Patients on Hemodialysis.口服多糖铁复合物治疗血液透析患者疗效与安全性的随机阳性对照研究
Kidney Int Rep. 2025 Mar 17;10(6):1742-1749. doi: 10.1016/j.ekir.2025.03.017. eCollection 2025 Jun.
3

本文引用的文献

1
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.孕期静脉注射羧麦芽糖铁治疗缺铁和缺铁性贫血
Arch Gynecol Obstet. 2018 Jul;298(1):75-82. doi: 10.1007/s00404-018-4782-9. Epub 2018 May 8.
2
Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review.静脉注射聚麦芽糖铁、蔗糖铁和羧基麦芽糖铁在孕期的安全性和有效性:一项系统评价。
Aust N Z J Obstet Gynaecol. 2018 Feb;58(1):22-39. doi: 10.1111/ajo.12695. Epub 2017 Sep 18.
3
Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients with Reduced Ejection Fraction and Iron Deficiency.
静脉注射蔗糖铁用于射血分数降低且缺铁的急性失代偿性心力衰竭患者
Rev Cardiovasc Med. 2025 Apr 17;26(4):28216. doi: 10.31083/RCM28216. eCollection 2025 Apr.
4
Evaluation of therapeutic response and tolerability to intravenous iron sucrose and ferric carboxymaltose among pregnant women with iron?deficiency anemia: A 6?year experience in a tertiary care center.缺铁性贫血孕妇对静脉注射蔗糖铁和羧基麦芽糖铁的治疗反应及耐受性评估:一家三级护理中心的6年经验。
Med Int (Lond). 2025 Apr 3;5(4):34. doi: 10.3892/mi.2025.233. eCollection 2025 Jul-Aug.
5
Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.羧基麦芽糖铁和蔗糖铁治疗缺铁性贫血的疗效、安全性及耐受性:一项随机对照试验的系统评价和荟萃分析
Turk J Haematol. 2025 May 22;42(2):119-135. doi: 10.4274/tjh.galenos.2025.2025.0034. Epub 2025 Mar 17.
6
Intravenous iron sucrose when administered to moderately anemic pregnant women raises the hemoglobin concentration and replenishes body iron at 6 months.给中度贫血的孕妇静脉注射蔗糖铁,可提高血红蛋白浓度,并在6个月时补充体内铁。
J Family Med Prim Care. 2024 Nov;13(11):5009-5013. doi: 10.4103/jfmpc.jfmpc_725_24. Epub 2024 Nov 18.
7
Pregnancy in patients with chronic kidney disease undergoing dialysis.透析治疗的慢性肾脏病患者的妊娠问题。
J Bras Nefrol. 2024 Oct-Dec;46(4):e20240067. doi: 10.1590/2175-8239-JBN-2024-0067en.
8
Comparative analysis of ferric carboxymaltose and iron sucrose in treating iron deficiency anemia in perimenopausal women with heavy menstrual bleeding: a randomized controlled trial.羧基麦芽糖铁与蔗糖铁治疗围绝经期月经过多妇女缺铁性贫血的比较分析:一项随机对照试验
Obstet Gynecol Sci. 2024 Nov;67(6):565-573. doi: 10.5468/ogs.24065. Epub 2024 Nov 4.
9
Prevalence of iron overload in patients with chronic kidney disease on peritoneal dialysis: A scoping review.腹膜透析慢性肾病患者铁过载的患病率:一项范围综述。
Health Sci Rep. 2024 Sep 8;7(9):e2255. doi: 10.1002/hsr2.2255. eCollection 2024 Sep.
10
Iron-deficiency Anemia Treatment with Ferric Carboxymaltose: A Real-world Quasi-experimental Study from Bangladesh.用羧基麦芽糖铁治疗缺铁性贫血:来自孟加拉国的一项真实世界的准实验研究。
Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):12-15. doi: 10.5005/jp-journals-10018-1422.
羧基麦芽糖铁与口服铁剂治疗缺铁性贫血孕妇的疗效比较:一项国际、开放标签、随机对照试验(FER-ASAP)
J Perinat Med. 2017 May 24;45(4):443-453. doi: 10.1515/jpm-2016-0050.
4
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.比较羧基麦芽糖铁和蔗糖铁治疗因异常子宫出血导致的缺铁性贫血的随机对照试验。
Int J Gynaecol Obstet. 2016 Apr;133(1):43-8. doi: 10.1016/j.ijgo.2015.09.007. Epub 2015 Dec 23.
5
Intravenous ferric carboxymaltose for anaemia in pregnancy.静脉注射羧麦芽糖铁治疗妊娠期贫血
BMC Pregnancy Childbirth. 2014 Mar 25;14:115. doi: 10.1186/1471-2393-14-115.
6
Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy.静脉注射蔗糖铁治疗妊娠中重度贫血。
Indian J Med Res. 2013;138(1):78-82.
7
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.妊娠期静脉铁治疗:高剂量羧基麦芽糖铁与蔗糖铁的比较。
J Perinat Med. 2012 May 13;40(5):469-74. doi: 10.1515/jpm-2011-0231.
8
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.FERGIcor 研究:一项评估羧基麦芽糖铁治疗炎症性肠病缺铁性贫血的随机对照试验
Gastroenterology. 2011 Sep;141(3):846-853.e1-2. doi: 10.1053/j.gastro.2011.06.005. Epub 2011 Jun 12.
9
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.大剂量静脉注射羧甲司坦铁治疗严重子宫出血所致缺铁性贫血的随机对照试验。
Transfusion. 2009 Dec;49(12):2719-28. doi: 10.1111/j.1537-2995.2009.02327.x. Epub 2009 Jul 22.
10
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.静脉注射羧麦芽糖铁与口服铁剂治疗产后贫血的比较:一项随机对照试验。
Obstet Gynecol. 2007 Aug;110(2 Pt 1):267-78. doi: 10.1097/01.AOG.0000275286.03283.18.